Related references
Note: Only part of the references are listed.IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments
S. Grkovic et al.
ONCOGENE (2013)
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
A. Gallardo et al.
BRITISH JOURNAL OF CANCER (2012)
Bone-Derived IGF Mediates Crosstalk between Bone and Breast Cancer Cells in Bony Metastases
Toru Hiraga et al.
CANCER RESEARCH (2012)
Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer
Jabed Iqbal et al.
HISTOPATHOLOGY (2012)
The many faces of insulin-like peptide signalling in the brain
Ana M. Fernandez et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy
Renata Duchnowska et al.
ONCOLOGIST (2012)
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
Beate C. Litzenburger et al.
CLINICAL CANCER RESEARCH (2011)
Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3
Janet L. Martin et al.
GROWTH FACTORS (2011)
Protein Pathway Activation Mapping of Brain Metastasis from Lung and Breast Cancers Reveals Organ Type Specific Drug Target Activation
Giuseppina Improta et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
Zoe Davison et al.
NEOPLASIA (2011)
Brain metastases as preventive and therapeutic targets
Patricia S. Steeg et al.
NATURE REVIEWS CANCER (2011)
Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
Paul R. Lockman et al.
CLINICAL CANCER RESEARCH (2010)
Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic properties
Vladislava Paharkova-Vatchkova et al.
ENDOCRINE-RELATED CANCER (2010)
DIAGNOSIS-SPECIFIC PROGNOSTIC FACTORS, INDEXES, AND TREATMENT OUTCOMES FOR PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES: A MULTI-INSTITUTIONAL ANALYSIS OF 4,259 PATIENTS
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
All-Atom Structural Models for Complexes of Insulin-Like Growth Factors IGF1 and IGF2 with Their Cognate Receptor
Harish Vashisth et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
Shucheng Yin et al.
NEURO-ONCOLOGY (2010)
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival
D. Sachdev et al.
ONCOGENE (2010)
Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells
Michelle K. O'Han et al.
GROWTH FACTORS (2009)
Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity
Janet L. Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Vascular Basement Membrane as Soil'' in Brain Metastasis
W. Shawn Carbonell et al.
PLOS ONE (2009)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Breast cancer brain metastases
Xiaoyun Cheng et al.
CANCER AND METASTASIS REVIEWS (2007)
Association of insulin-like growth factor binding protein-3 expression with melanoma progression
Yaguang Xi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells
T Strömberg et al.
BLOOD (2006)
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
E Menu et al.
BLOOD (2006)
Breast cancer metastasis to the central nervous system
RJ Weil et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: The role of altered epidermal growth factor signaling
AJ Butt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-α is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells
U Sivaprasad et al.
ENDOCRINOLOGY (2004)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phosphorylation/cytoplasmic localization of p2lCip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients
WY Xia et al.
CLINICAL CANCER RESEARCH (2004)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
D Vasilcanu et al.
ONCOGENE (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events
PO Krutzik et al.
CYTOMETRY PART A (2003)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin
C McCaig et al.
JOURNAL OF CELL SCIENCE (2002)
Role of insulin-like growth factor binding protein-3 in breast cancer cell growth
LJ Schedlich et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis
T Lopez et al.
CANCER CELL (2002)
Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines
JG Jackson et al.
ONCOGENE (2001)
A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro
T Yoneda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Role of the insulin-like growth factor family in cancer development and progression
H Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
